Xopenex - Newsfeeds

Xopenex HFA Product Review: Xopenex HFA is levalbuterol tartrate inhalation aerosol. Xopenex HFA is made by Sepracor Inc and does not come in generic form. Xopenex HFA: Use : Xopenex HFA is used when symptoms of asthma are present. As prescribed to ...
Asthma medications: Know your options: Quick-relief medications include: Albuterol (AccuNeb, Ventolin, others) Levalbuterol (Xopenex HFA) Pirbuterol (Maxair Autohaler) If your symptoms are minor and infrequent, or you have exercise-induced asthma, you may be ...
Xopenex HFA Product Review: Xopenex HFA: Personal Reaction: My wife loves the switch from Albuterol to Xopenex HFA. According to my wife when she would take Albuterol or Ventolin it would speed up her heart rate and cause her to shake at times. The ...
Asthma 'Rescue' Inhalers Are Changing: The inhalers included in the changeover contain albuterol or levalbuterol, active ingredients that help quickly open the airways during an asthma attack. Inhalers that contain corticosteroids -- medications that prevent asthma attacks from occurring ...
Asthma inhalers now more eco-friendly: The CFC-free options: GlaxoSmithKline’s Ventolin HFA, Schering Plough’s Proventil HFA and Teva Specialty Pharmaceuticals’ ProAir HFA all contain albuterol. Also, Sepracor’s Xopenex HFA contains the similar medication levalbuterol. Albuterol ...
Sepracor Announces Tender Offer for 0% Convertible Senior Subordinated ...: Currently marketed products include LUNESTA® brand eszopiclone, XOPENEX® brand levalbuterol HCl Inhalation Solution, XOPENEX HFA® brand levalbuterol tartrate Inhalation Aerosol, BROVANA® brand arformoterol tartrate Inhalation Solution, OMNARIS ...
Sepracor Reports Preliminary Phase II Study Results For SEP-225441 For ...: Currently marketed products include LUNESTA ® brand eszopiclone, XOPENEX ® brand levalbuterol HCl Inhalation Solution, XOPENEX HFA® brand levalbuterol tartrate Inhalation Aerosol, BROVANA ® brand arformoterol tartrate Inhalation Solution, OMNARIS ...
Hanrahan joins Pulmatrix as chief medical officer: Prior to joining Pulmatrix, Hanrahan worked as executive medical director for pulmonary products at pharmaceutical company Sepracor Inc., where he was responsible for clinical development for FDA approval of the firm’s asthma drug Levalbuterol and ...
3 Miami men plead guilty in Medicare fraud: ... 36, who is to be sentenced in August, was indicted on healthcare fraud and money-laundering offenses while operating BJB Pharmacy Discount between 2005 and 2008, admitted billing the federal program for aerosol medicines such as levalbuterol. They ...
Watson to go global with $1.75 billion Arrow buy: Watson also gains exclusive rights to launch a generic version of Sepracor's (SEPR.O) Xopenex asthma drug in 2012, and assumes a patent challenge of AstraZeneca Plc's (AZN.L) Pulmicort asthma medicine, Bisaro said. Overall, he said, the two companies ...

Watson Pharmaceuticals (NYSE: WPI) Buys Arrow Group for $1.75B: It is also one of the companies challenging the patent on AstraZeneca PLC's asthma drug Pulmicort, and has the right to start selling a generic version of Sepracor Inc.'s respiratory drug Xopenex starting in August 2012. Watson reported $2.54 billion ...
Obama’s Plan to Fund D.C. Abortions Shows He Is Not Seeking ...: Xopenex (2 months ago) He really pushes it, abortion, in ...
Local woman in critical condition with swine flu, pneumonia: The doctor went into freak mode and ordered a chest x-ray, then one of those nebulizers with Xopenex inhalation solution put in it and we had to go to back to the doctor over and over till she checked out ok. It never got to the point that her ...
Sepracor Inc. Reports Strong Second Quarter 2009 Operating Results and ...: XOPENEX Inhalation Solution revenues for the first half of 2009 were $208.0 million versus $225.4 million for the first half of 2008. XOPENEX HFA ® brand levalbuterol tartrate Inhalation Aerosol, a hydrofluoroalkane (HFA) metered ...
Sepracor 2Q profit falls, but handily tops view: Sales of the solution form of Xopenex, a respiratory drug, grew to $89.9 million from $85.4 million, and revenue from the aerosol form of Xopenex grew to $14.8 million from $14.1 million. Sales of the lung disease treatment Brovana grew to $19.1 ...
These 5 Stocks Have a Little Magic: Drugs like Xopenex, Lunesta, and Brovana have given the company a firm revenue stream. Management has been cutting overhead costs, which should free up more money for clinical trials. The key question for Sepracor will be seeing how its pipeline ...
CNBC'S MOST SHARED: Sales from Xopenex inhaled solution fell to $104.9 million from $115.7 million a year ago, also short of expectations. "The outlook for Lunesta is difficult, the outlook for Xopenex is difficult, and they don't have much in their pipeline," Sanderson ...
Fitch Rates Watson Pharmaceuticals' Proposed Sr. Unsecured Notes 'BBB ...: ... pipeline, which includes the rights to launch the authorized generic version of Lipitor in November 2011 (which will have a profit-sharing agreement with Arrow's shareholders) and exclusive rights to the generic version of Xopenex ...
Fitch Rates Watson Pharmaceuticals' Proposed Sr. Unsecured Notes 'BBB ...: ... from Arrow's pipeline, which includes the rights to launch the authorized generic version of Lipitor in November 2011 (which will have a profit-sharing agreement with Arrow's shareholders) and exclusive rights to the generic version of Xopenex in ...

Want to contact a Xopenex attorney in Washington, DC?...Get a free case evaluation from one of our Xopenex attorneys in Washington, DC now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need A Xopenex Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Xopenex Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Xopenex Information

Click to View Our Legal Resources

Want to contact a Xopenex attorney in Washington, DC?...Get a free case evaluation from one of our Xopenex attorneys in Washington, DC now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120128-054655

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Xopenex Click to select a Legal Issue

Close (x)

Find Legal Help for Your Xopenex Case - Submit Your Information Below

Do you need legal assistance with your Xopenex case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Xopenex Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.